24
Participants
Start Date
June 14, 2017
Primary Completion Date
May 2, 2019
Study Completion Date
May 2, 2019
SC-004
Intravenous
ABBV-181
Intravenous
University of Alabama /ID# 202249, Birmingham
The Ohio State University - Columbus /ID# 164089, Columbus
Henry Ford Health System /ID# 202480, Detroit
University of Chicago /ID# 200735, Chicago
Washington University School /ID# 164091, St Louis
Univ Oklahoma HSC /ID# 164090, Oklahoma City
MD Anderson Cancer Center /ID# 200048, Houston
City of Hope /ID# 202493, Duarte
Highlands Oncology Group /ID# 209165, Fayetteville
Mayo Clinic - Rochester /ID# 200732, Rochester
Tennessee Oncology-Nashville Centennial /ID# 164088, Nashville
Huntsman Cancer Institute /ID# 209164, Salt Lake City
Lead Sponsor
AbbVie
INDUSTRY